Volume : 8
Issue : S1
COVID-19 and cardiovascular disease
Suri P, Arora V
Pdf Page Numbers :- 69-73
Pawan Suri1 and Vanita Arora2,*
1SGL Superspeciality Hospital, Jalandhar, Punjab-144022, India
2Cardiac Electrophysiology Laboratory & Arrhythmia Services, Max Healthcare Superspeciality Hospital, Saket, New Delhi-110017, India
*Corresponding author: Dr. Vanita Arora, MD; DNB (Cardiology); FRCP (Edin)., Director & Head, Cardiac Electrophysiology lab & Arrhythmia Services, Max Healthcare Superspeciality Hospital, Saket, New Delhi-110017, India. Email: firstname.lastname@example.org
Received 15 September 2020; Revised 30 October 2020; Accepted 14 November 2020; Published 24 November 2020
Citation: Suri P, Arora V. COVID-19 and cardiovascular disease. J Med Sci Res. 2020; 8(S1):69-73. DOI: http://dx.doi.org/10.17727/JMSR.2020/8S1-8
Copyright: © 2020 Suri P et al. Published by KIMS Foundation and Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
View Full Text
Coronavirus disease 2019 (COVID-19), a spectrum of disease spanning from a barely symptomatic infection to critical illness, is caused by the new coronavirus - severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Although lung injury and acute respiratory distress syndrome have been at a centre stage as the most dreadful complications of COVID-19, the heart damage has recently emerged as yet another grim outcome in the virus’s repertoire of possible complications. The cardiac involvement occurs as a direct invasion of cardiomyocytes by the virus via the angiotensin‐converting enzyme 2 (ACE2) receptors and also indirectly by the inflammatory reaction due to cytokine storm. COVID-19 increases the severity of an already pre-existing heart disease and also unmasks the cardiac symptoms in a previously undiagnosed heart disease as well. Apart from this the drugs that are repurposed and are supposed to have a preventive or a therapeutic potential are also supposedly causing cardiac side effects. In the absence of substantial database all these seem to be a hypothetical correlation and one needs to rely on clinical skills and acumen.
Keywords: COVID-19; SARS-CoV-2; cardiovascular disease; acute respiratory distress syndrome